Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Overview

We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable.

News

News Startup to Follow 2 years ago
Revolutionizing Colorectal Cancer Screening One Blood Test at a Time
Universal DX is a biotech company dedicated to transforming cancer into a curable disease by detecting it early. Through bioinformatics and multi-omics,…
Read more
Report
News genomeweb.com 3 years ago
Universal DX Closes $70M Series B Round, Inks Deal With Quest to Provide Colorectal Cancer Test
Under the agreement, Quest, an investor in the round, will have exclusive rights to provide Universal's Signal-C colorectal cancer screening test in the US.
Read more
Report
Press release PRNewswire 3 years ago
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
/PRNewswire/ -- Universal DX ("UDX"), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic collaboration with...
Read more
Report
News Nasdaq 3 years ago
Quest Collaborates With Universal DX For Advanced Blood Test Screening For Colorectal Cancer
(RTTNews) - Quest Diagnostics Incorporated (DGX) on Monday entered into a strategic collaboration with Universal DX that aims to revolutionize the way colorectal cancer screening is performed in the United States.
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Technologies

Sign in to see how your skills match this stack
Sign In
Data Science
Microsoft Excel
Other
Outlook
Microsoft Office
Jira
Smartsheet
Stack modernity Modern
60/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
In-demand technologies
Outlook 1 job Required
Microsoft Office 1 job Required
Microsoft Excel 1 job Required
Smartsheet 1 job Required
Jira 1 job Required
Salary medians are calculated from this company's open jobs and compared with the market.
Industry adoption
Microsoft Office
12%
Microsoft Excel
10%
Jira
7%
Outlook
6%
Smartsheet
3%
Share of companies in the same industry that use each technology.
Stack changes
Smartsheet Sep 2026
Jira Sep 2026
Microsoft Excel Sep 2026
Microsoft Office Sep 2026
Outlook Sep 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.

Growth

Hiring Momentum
51/100
Stable
Open positions
6
0 opened / 1 closed in 30 days
Median time-to-fill
52 days
faster than 29% of the market
ATS activity
Every ~2 hours
Today
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Industrial Engineering
50% ▲
Science & Research
25% ▲
Product
13% ▼
Legal
13% ▼
Actively hiring for Industrial Engineering (+3 in 30 days)
Activity Timeline
Added Microsoft Office to stack Sep 2026
Added Outlook to stack Sep 2026

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Dallas
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Dallas United States
Plant / site
United States
5 open roles 5 posted in 90 days 40% engineering
hires for Industrial Engineering, Science & Research
3020 Pegasus Park Drive, Suite 140, Dallas, TX 75247
seen since Aug 2026 company site, job postings

Financials

Total raised
$70M
Latest round
Series B
Funding rounds
1
Funding rounds
Round Announced Amount
Series B 2023 $70M Details